Table 2. Angiographic data.
|
Variables |
n = 20 |
|
Duration from AD (months), median (IQR) |
32.5 (8.8–76.5) |
|
Procedure duration (min), median (IQR) |
124.0 (78.5–158.5) |
|
Scopy duration (min), median (IQR) |
17.4 (12.1–24.3) |
|
Dose (Gy.cm2), median (IQR) |
175.2 (59.1–319.2) |
|
CFLO single technique, n (%) |
7 (35.0) |
|
CFLO combined technique, n (%) |
13 (65.0) |
|
Occlusion material used*, n (%) | |
|
Coil |
5 (25.0) |
|
Coil + glue |
2 (10.0) |
|
Coil + plug |
3 (15.0) |
|
Coil + SAT stenting |
2 (10.0) |
|
Glue + plug |
2 (10.0) |
|
Plug + SAT stenting |
2 (10.0) |
|
Plug |
2 (10.0) |
|
Coil + glue + plug |
2 (10.0) |
|
Total number of CFLO sessions, median (IQR) |
1.5 (1.0–2.3) |
|
Patients with ≥2 CFLO sessions, n (%) |
10 (50.0) |
|
Isolated CFLO** |
10 (50.0) |
|
Additional TEVAR treatment after CFLO, n (%) |
4 (20.0) |
|
Interval to CFLO after TEVAR (months), median (IQR) |
6.6 (1.5–16.7) |
|
Interval to TEVAR after CFLO (months), median (IQR) |
10.2 (4.9–16.9) |
*Considering all CFLO sessions; **isolated CFLO = CFLO without prior or additional TEVAR; n, number; AD, aortic dissection; IQR, interquartile range; CFLO, circulating false lumen occlusion; SAT, supra-aortic trunk; TEVAR, thoracic endovascular aortic repair.